Moreover, from a biological point of view, SERPINB2 regulates the plasminogen activator-2 inhibitor pathway, which is responsible for a fibrinolytic mechanism that is less associated with APS-related hypercoagulability. The gene discussed is SERPINB2; the disease is autoimmune polyendocrinopathy.